Specialized proresolving mediators: Benefits within and beyond inflammation resolution in cardiometabolic, neurological and psychiatric disorders

Data de publicação:

Autores da FMUP

  • Teresa Maria De Jesus Teixeira De Sousa

    Autor

  • Dora Raquel Da Silva Pinho

    Autor

Participantes de fora da FMUP

  • Recchiuti, A
  • Isopi, E
  • Verri, W

Unidades de investigação

Abstract

[No abstract available]

Dados da publicação

ISSN/ISSNe:
1664-042X, 1664-042X

Frontiers in Physiology  Frontiers Media S.A.

Tipo:
Editorial Material
Páginas:
-
Link para outro recurso:
www.scopus.com

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • specialized proresolving lipid mediators; inflammation; cardiometabolic disorders; neurological diseases; psychiatric disease

Financiamento

Proyectos asociados

Unresolved inflammation and endothelitis in severe COVID-19 patients: identification of risk stratification biomarkers and therapeutic targets. (severe COVID-19)

Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa

Estudo Clínico Académico (Severe COVID-19) . FCT . 2020

Endocan: a novel biomarker for risk stratification, prognosis, and therapeutic monitoring in human cardiovascular and renal diseases

Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa

Estudo Clínico Académico (Endocan) . 2020

Renal renin-angiotensin system activation in acute heart failure and its association with endothelial dysfunction, inflammation and oxidative stress.

Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa

Estudo Clínico Académico (Renal) . 2021

Urinary cysteinyl leukotrienes as biomarkers of endothelial activation, inflammation and oxidative stress and their relationship with organ dysfunction in human septic shock

Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa

Estudo Clínico Académico . 2021

Evaluation of 11-dehydro-thromboxane B2 as a biomarker of severity and putative therapeutic target in human acute heart failure and cardiogenic shock

Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa

Estudo Clínico Académico . 2022

Endothelial dysfunction in different stages of diseases severity of COVID-19: focus on endocan and arterial hypertension

Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa

Estudo Clínico Académico . 2022

Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients

Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa

Estudo Clínico Académico . 2022

Citar a publicação

Partilhar a publicação